vs
藏寿司（KRUS）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
藏寿司的季度营收约是RIGEL PHARMACEUTICALS INC的1.1倍（$73.5M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -4.2%，领先388.2%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 14.0%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 13.2%）
藏寿司是日本知名回转寿司连锁品牌，为日本第二大寿司连锁企业，规模仅次于寿司郎，领先滨寿司。品牌总部设于大阪府堺市，目前在日本拥有543家门店，在中国台湾地区开设56家门店，另在美国布局有69家门店。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
KRUS vs RIGL — 直观对比
营收规模更大
KRUS
是对方的1.1倍
$69.8M
营收增速更快
RIGL
高出7.2%
14.0%
净利率更高
RIGL
高出388.2%
-4.2%
两年增速更快
RIGL
近两年复合增速
13.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $73.5M | $69.8M |
| 净利润 | $-3.1M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | -5.0% | 33.2% |
| 净利率 | -4.2% | 384.0% |
| 营收同比 | 14.0% | 21.2% |
| 净利润同比 | -218.4% | 1769.2% |
| 每股收益（稀释后） | $-0.25 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KRUSRIGL
| Q4 25 | $73.5M | $69.8M | ||
| Q3 25 | $79.4M | $69.5M | ||
| Q2 25 | $74.0M | $101.7M | ||
| Q1 25 | $64.9M | $53.3M | ||
| Q4 24 | $64.5M | $57.6M | ||
| Q3 24 | $66.0M | $55.3M | ||
| Q2 24 | $63.1M | $36.8M | ||
| Q1 24 | $57.3M | $29.5M |
净利润KRUSRIGL
| Q4 25 | $-3.1M | $268.1M | ||
| Q3 25 | $2.3M | $27.9M | ||
| Q2 25 | $565.0K | $59.6M | ||
| Q1 25 | $-3.8M | $11.4M | ||
| Q4 24 | $-961.0K | $14.3M | ||
| Q3 24 | $-5.2M | $12.4M | ||
| Q2 24 | $-558.0K | $-1.0M | ||
| Q1 24 | $-998.0K | $-8.2M |
毛利率KRUSRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率KRUSRIGL
| Q4 25 | -5.0% | 33.2% | ||
| Q3 25 | 1.8% | 40.9% | ||
| Q2 25 | -0.2% | 60.1% | ||
| Q1 25 | -7.1% | 23.9% | ||
| Q4 24 | -2.3% | 28.9% | ||
| Q3 24 | -8.8% | 25.4% | ||
| Q2 24 | -1.9% | 1.2% | ||
| Q1 24 | -2.9% | -23.6% |
净利率KRUSRIGL
| Q4 25 | -4.2% | 384.0% | ||
| Q3 25 | 2.9% | 40.2% | ||
| Q2 25 | 0.8% | 58.6% | ||
| Q1 25 | -5.8% | 21.5% | ||
| Q4 24 | -1.5% | 24.9% | ||
| Q3 24 | -7.9% | 22.5% | ||
| Q2 24 | -0.9% | -2.8% | ||
| Q1 24 | -1.7% | -27.9% |
每股收益（稀释后）KRUSRIGL
| Q4 25 | $-0.25 | $14.11 | ||
| Q3 25 | $0.18 | $1.46 | ||
| Q2 25 | $0.05 | $3.28 | ||
| Q1 25 | $-0.31 | $0.63 | ||
| Q4 24 | $-0.08 | $0.82 | ||
| Q3 24 | $-0.47 | $0.70 | ||
| Q2 24 | $-0.05 | $-0.06 | ||
| Q1 24 | $-0.09 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $50.7M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $229.2M | $391.5M |
| 总资产 | $443.5M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资KRUSRIGL
| Q4 25 | $50.7M | $155.0M | ||
| Q3 25 | $62.5M | $137.1M | ||
| Q2 25 | $60.5M | $108.4M | ||
| Q1 25 | $85.2M | $77.1M | ||
| Q4 24 | $107.7M | $77.3M | ||
| Q3 24 | $51.0M | $61.1M | ||
| Q2 24 | $60.7M | $49.1M | ||
| Q1 24 | $62.8M | $49.5M |
总债务KRUSRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益KRUSRIGL
| Q4 25 | $229.2M | $391.5M | ||
| Q3 25 | $231.1M | $117.6M | ||
| Q2 25 | $227.0M | $81.9M | ||
| Q1 25 | $225.0M | $18.6M | ||
| Q4 24 | $227.6M | $3.3M | ||
| Q3 24 | $162.5M | $-14.6M | ||
| Q2 24 | $166.4M | $-29.9M | ||
| Q1 24 | $165.3M | $-31.7M |
总资产KRUSRIGL
| Q4 25 | $443.5M | $513.6M | ||
| Q3 25 | $430.9M | $242.5M | ||
| Q2 25 | $419.4M | $206.7M | ||
| Q1 25 | $410.4M | $176.0M | ||
| Q4 24 | $403.8M | $164.0M | ||
| Q3 24 | $328.5M | $139.4M | ||
| Q2 24 | $324.7M | $128.4M | ||
| Q1 24 | $315.5M | $126.5M |
负债/权益比KRUSRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $529.0K | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-13.3M | — |
| 自由现金流率自由现金流/营收 | -18.1% | — |
| 资本支出强度资本支出/营收 | 18.8% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-27.5M | — |
8季度趋势，按日历期对齐
经营现金流KRUSRIGL
| Q4 25 | $529.0K | $22.0M | ||
| Q3 25 | $9.4M | $24.0M | ||
| Q2 25 | $6.7M | $30.5M | ||
| Q1 25 | $4.3M | $-893.0K | ||
| Q4 24 | $4.4M | $14.5M | ||
| Q3 24 | $669.0K | $21.7M | ||
| Q2 24 | $8.7M | $302.0K | ||
| Q1 24 | $3.8M | $-5.0M |
自由现金流KRUSRIGL
| Q4 25 | $-13.3M | — | ||
| Q3 25 | $-79.0K | — | ||
| Q2 25 | $-6.9M | — | ||
| Q1 25 | $-7.3M | — | ||
| Q4 24 | $-7.2M | — | ||
| Q3 24 | $-9.6M | — | ||
| Q2 24 | $-2.4M | — | ||
| Q1 24 | $-9.7M | — |
自由现金流率KRUSRIGL
| Q4 25 | -18.1% | — | ||
| Q3 25 | -0.1% | — | ||
| Q2 25 | -9.3% | — | ||
| Q1 25 | -11.2% | — | ||
| Q4 24 | -11.2% | — | ||
| Q3 24 | -14.6% | — | ||
| Q2 24 | -3.8% | — | ||
| Q1 24 | -16.9% | — |
资本支出强度KRUSRIGL
| Q4 25 | 18.8% | — | ||
| Q3 25 | 11.9% | — | ||
| Q2 25 | 18.4% | — | ||
| Q1 25 | 17.8% | — | ||
| Q4 24 | 17.9% | — | ||
| Q3 24 | 15.6% | — | ||
| Q2 24 | 17.6% | — | ||
| Q1 24 | 23.5% | — |
现金转化率KRUSRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 4.12× | 0.86× | ||
| Q2 25 | 11.88× | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
